We performed a systematic review to quantify the amount of evidence-based data available on patient-reported outcomes (PRO) in Relapsed/Refractory Multiple Myeloma (RRMM) patients and to examine the added value of such studies in supporting clinical decision-making.
Sparano, F., Cavo, M., Niscola, P., Caravita, T., Efficace, F. (2018). Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review. SUPPORTIVE CARE IN CANCER, 26(7), 2075-2090 [10.1007/s00520-018-4137-x].
Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review
Cavo, Michele;
2018
Abstract
We performed a systematic review to quantify the amount of evidence-based data available on patient-reported outcomes (PRO) in Relapsed/Refractory Multiple Myeloma (RRMM) patients and to examine the added value of such studies in supporting clinical decision-making.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
